跳至主要内容
欧盟官方标签名称词汇表条目 10035

ETHYL CAFFEATE

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 0 个有匹配的监管证据:0 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

0 个市场有证据
已检查的市场
13
有证据的市场
0
证据缺口
13
已解析的标识符
1

已解析的物质身份

CAS:102-37-4
成分索引记录:
ETHYL CAFFEATE
化妆品功能: SKIN CONDITIONING

2-Propenoic Acid, 3-(3,4-Dihydroxyphenyl)-, Ethyl Ester

1 个匹配或报告的名称
ETHYL CAFFEATE

跨市场监管证据

此处跟踪的 13 个市场均没有以 ETHYL CAFFEATE 为名的已导入规则。

这是关于本清单的陈述,而非关于法律的陈述:没有已导入的规则并不能证明某物质获准使用。规则可能以其他名称存在,或以本词汇表条目未载有的 CAS 或 EC 编号存在,或存在于尚未导入的数据集中。

化学身份与性质

CAS 102-37-4 的 PubChem 二维化学结构
CAS 102-37-4PubChem CID 5317238

Ethyl Caffeate

Ethyl trans-caffeate is an ethyl ester resulting from the formal condensation of the carboxy group of trans-caffeic acid with ethanol. It has a role as an antineoplastic agent and an anti-inflammatory agent. It is an ethyl ester and an alkyl caffeate ester. It is functionally related to a trans-caffeic acid. — ChEBI

IUPAC 名称
ethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
分子式
C11H12O4
分子量
208.21 g/mol
精确质量
208.07355886 Da
XLogP3
2.6
拓扑极性表面积
66.8 Ų
氢键供体
2
氢键受体
4
共价单元
1
已定义的立体中心
0

又称

ethyl trans-caffeateEthyl 3,4-dihydroxycinnamateCaffeic acid ethyl ester76GBB1JU5YCHEBI:132714RefChem:596426108-430-1Ethyl 3-(3,4-dihydroxyphenyl)acrylate
另有 16 个已报告名称
(E)-Ethyl Dihydroxycinnamate(E)-ethyl caffeate4gqqEthyl (2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate(E)-ethyl 3-(3,4-dihydroxyphenyl)acrylateHY-N6966NSC-619661AC-34380ethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, ethyl ester3-(3,4-Dihydroxy-phEthyl (E)-3-(3,4-dihydroxyphenyl)acrylateUNII-76GBB1JU5Y3,4-Dihydroxycinnamic acid ethyl ester3-(3,4-Dihydroxy-phenyl)-acrylic acid ethyl esterEthyl caffeate [M+H]+
外部数据库标识符

来自其他科学数据库的证据

EMBL-EBI ChEBI
标识符精确匹配CHEBI:132714

ethyl trans-caffeate

An ethyl ester resulting from the formal condensation of the carboxy group of trans-caffeic acid with ethanol.

配方
C11H12O4
平均质量
208.213 g/mol
单同位素质量
208.07356 Da
形式电荷
0
  • alkyl caffeate ester — is a (CHEBI:65331)
  • ethyl ester — is a (CHEBI:23990)
  • anti-inflammatory agent — has role (CHEBI:67079)
  • antineoplastic agent — has role (CHEBI:35610)
  • trans-caffeic acid — has functional parent (CHEBI:16433)
  • anti-inflammatory agent — has role (CHEBI:67079)
  • antineoplastic agent — has role (CHEBI:35610)
  • alkyl caffeate ester — is a (CHEBI:65331)
  • ethyl ester — is a (CHEBI:23990)
其他整理的名称
ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoateethyl (2E)-3-(3,4-dihydroxyphenyl)acrylateethyl 3,4-dihydroxycinnamateethyl caffeate(E)-ethyl 3-(3,4-dihydroxyphenyl)acrylate(E)-ethyl 3,4-dihydroxycinnamate(E)-ethyl caffeate
来自此来源的交叉引用
  • CAS: 102-37-4 — ChemIDplus
  • REGISTRY_NUMBER: 2106401 — Reaxys
  • MANUAL_X_REF: 5317238 — PubChem Compound
  • MANUAL_X_REF: Ethyl_caffeate — Wikipedia

映射方: Exact CAS cross-reference in the ChEBI compound record. 来源更新: 2016-08-04. 检索时间: 2026-08-31. 打开来源记录

NIH PubChem PUG-View
标识符精确匹配5317238

Attributed physical-property, hazard, environmental and use annotations.

  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (80%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (80%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (80%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 5 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. 来源: European Chemicals Agency (ECHA)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI精确匹配2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定